Retraction note to: Recent advances for the treatment of cocaine abuse: central nervous system immunopharmacotherapy
Journal Title: The AAPS Journal - Year 2012, Vol 14, Issue 3
Abstract
The online version of the original article can be found at http://dx.doi.org10.1208/aapsj070359.
Authors and Affiliations
Tobin J. Dickerson, Kim D. Janda
Keywords
Related Articles
- EP ID EP681253
- DOI 10.1208/s12248-012-9365-2
- Views 53
- Downloads 0
Establishing the Quantitative Relationship Between Lanreotide Autogel®, Chromogranin A, and Progression-Free Survival in Patients with Nonfunctioning Gastroenteropancreatic Neuroendocrine Tumors
The online version of this article (doi:10.1208/s12248-016-9884-3) contains supplementary material, which is available to authorized users.
Development of a Preclinical PK/PD Model to Assess Antitumor Response of a Sequential Aflibercept and Doxorubicin-Dosing Strategy in Acute Myeloid Leukemia
Timing of the anti-angiogenic agent with respect to the chemotherapeutic agent may be crucial in determining the success of combination therapy in cancer. We investigated the effects of sequential therapy with the potent...
Blood pressure as an example of a biomarker that functions as a surrogate
There are many important uses of biomarkers in drug development. An area of particular interest is the use of biomarkers as surrogate end points. Only a small minority of biomarkers are established surrogate end points....
Vectors for airway gene delivery
Delivery of genes to the airway epithelium for therapeutic purposes seemed easy at first, because the epithelial cells interface with the environment and are therefore accessible. However, problems encountered were more...
Drug Delivery Approaches in Addressing Clinical Pharmacology-Related Issues: Opportunities and Challenges
Various drug delivery approaches can be used to maximize therapeutic efficacy and minimize side effects, by impacting absorption, distribution, metabolism, and elimination (ADME) of a drug compound. For those drugs with...